Therapeutic melanoma vaccines: Platforms, neoantigen strategies, and emerging combination immunotherapies.

Mhanna D, Salman B, El Hakim R, Aridi L, Abou Ali W, Al Halabi B, Faour V, Harb F, Azar S, Ghadieh HE

Open source

DOI
10.1177/25151355261488241
Published
2026
Container
Therapeutic advances in vaccines and immunotherapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/25151355261488241,
  title = {Therapeutic melanoma vaccines: Platforms, neoantigen strategies, and emerging combination immunotherapies.},
  author = {Mhanna D and Salman B and El Hakim R and Aridi L and Abou Ali W and Al Halabi B and Faour V and Harb F and Azar S and Ghadieh HE},
  year = {2026},
  journal = {Therapeutic advances in vaccines and immunotherapy},
  doi = {10.1177/25151355261488241},
  url = {https://doi.org/10.1177/25151355261488241}
}

RIS

TY  - JOUR
TI  - Therapeutic melanoma vaccines: Platforms, neoantigen strategies, and emerging combination immunotherapies.
AU  - Mhanna D
AU  - Salman B
AU  - El Hakim R
AU  - Aridi L
AU  - Abou Ali W
AU  - Al Halabi B
AU  - Faour V
AU  - Harb F
AU  - Azar S
AU  - Ghadieh HE
PY  - 2026
JO  - Therapeutic advances in vaccines and immunotherapy
DO  - 10.1177/25151355261488241
UR  - https://doi.org/10.1177/25151355261488241
ER  - 

APA

D, M., B, S., R, E. H., L, A., W, A. A., B, A. H., V, F., F, H., S, A., & HE, G. (2026). Therapeutic melanoma vaccines: Platforms, neoantigen strategies, and emerging combination immunotherapies.. Therapeutic advances in vaccines and immunotherapy. https://doi.org/10.1177/25151355261488241

Source records